Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
837
datasets available to search
ShareScore release 0.9.0
Dataset results
837 results for “endometrial cancer”
Lymph Node Mapping in Patients With Endometrial Cancer
ClinicalTrials.gov study NCT01818739. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer
ClinicalTrials.gov study NCT01045187. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma
ClinicalTrials.gov study NCT03395080. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
ClinicalTrials.gov study NCT00063999. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-
ClinicalTrials.gov study NCT03517449. IPD Sharing: Not stated. Countries: 21. Publications: 5.
Strain-elastography in Endometrial Cancer
ClinicalTrials.gov study NCT06623916. IPD Sharing: NO. Countries: 1. Publications: 1.
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
ClinicalTrials.gov study NCT01935934. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer
ClinicalTrials.gov study NCT01307631. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Association of Peripheral Monocytic-Myeloid-Derived Suppressor Cells with Molecular Subtypes in Single Center Endometrial Cancer Patients Receiving Carboplatin + Paclitaxel/Avelumab (MITO END-3 Trial)
<p><span>The MITO-END3 trial compared carboplatin and paclitaxel (</span><span>CP</span><span>) with avelumab plus carboplatin and paclitaxel (</span><span>CPA)</span><span> as first-line treatment in endometrial cancer (EC) patients and </span><span>demonstrated a significant interaction between avelumab response and mismatch repair status. To investigate prognostic/predictive biomarker, </span><span>twenty-nine MITO-END3-EC patients were evaluated at pre-treatment (B1) and at the end of CP/CPA treatment (B2) for </span><span>peripheral Myeloid derived suppressor cells (MDSC) and Tregs. </span><span>At B2, <span>effector</span> Tregs frequency was significantly higher in patients treated with CPA as compared to CP (p=0.038). Both treatments (CP/CPA) induced significant decrease in peripheral M-MDSC (-5.41%) in TCGA 2-MSI-High as compared to TCGA-category 4 tumors (p=0.004). In accordance, both treatments induced M-MDSCs (+5.34%) in MSS patients as compared to MSI-High patients (p=0.001). Moreover, in a subgroup of patients, </span><span>primary tumors were highly infiltrated by M-MDSCs in MSS as compared to MSI-high ECs. </span><span>A post hoc analysis displayed higher frequeny of M-MDSCs (p=0.020) and lower frequency of CD4+ (p<0.005) at pretreatment in EC patients as compared to healthy donors. </span><span>In conclusion, </span><span>the</span><span> peripheral evaluation of MDSCs and Tregs correlated with molecular features in EC treated with CP/CPA and may add insights in identifying EC patients responder to first line chemo/chemo-immunotherapy. </span></p>
Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer
ClinicalTrials.gov study NCT03503786. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)
ClinicalTrials.gov study NCT06486441. IPD Sharing: NO. Countries: 19. Publications: 1.
4FMFES-PET Imaging of Endometrial and Ovarian Cancers
ClinicalTrials.gov study NCT04823065. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?
ClinicalTrials.gov study NCT03570437. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison of Transvaginal Paracervical and Transperitoneal Approaches in Lymphadenectomy During v-NOTES Surgery for Patients Diagnosed With Endometrial Cancer
ClinicalTrials.gov study NCT06870903. IPD Sharing: YES. Countries: 1. Publications: 3.
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
ClinicalTrials.gov study NCT00770185. IPD Sharing: NO. Countries: 1. Publications: 1.
OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer
ClinicalTrials.gov study NCT01961102. IPD Sharing: Not stated. Countries: 1. Publications: 1.
DOstarlimab in Patients With Recurrent or dMMR/MSI-H Endometrial Cancer
ClinicalTrials.gov study NCT05728814. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
ClinicalTrials.gov study NCT00003624. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sexual Functioning in Endometrial Cancer
ClinicalTrials.gov study NCT00543192. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
ClinicalTrials.gov study NCT00002976. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.